Cargando…

MMP9 and IGFBP1 Regulate Tumor Immune and Drive Tumor Progression in Clear Cell Renal Cell Carcinoma

Immunotherapy is a novel approach and has been used in various diseases, especially in cancers. Recently, immunotherapy has gradually been used to treat advanced clear cell renal cell carcinoma (ccRCC) or metastatic ccRCC. However, the efficacy of immunotherapy is not satisfying due to the influence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Tianbo, Gao, Su, Liu, Jingchong, Huang, Yu, Chen, Ke, Zhang, Xiaoping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7974879/ https://www.ncbi.nlm.nih.gov/pubmed/33758602 http://dx.doi.org/10.7150/jca.48664

Ejemplares similares

METTL14 Acts as a Potential Regulator of Tumor Immune and Progression in Clear Cell Renal Cell Carcinoma
por: Xu, Tianbo, et al.
Publicado: (2021)

ISG20 serves as a potential biomarker and drives tumor progression in clear cell renal cell carcinoma
por: Xu, Tianbo, et al.
Publicado: (2020)

A Novel Ferroptosis-Related Pathway for Regulating Immune Checkpoints in Clear Cell Renal Cell Carcinoma
por: Gao, Su, et al.
Publicado: (2021)

RAC2 acts as a prognostic biomarker and promotes the progression of clear cell renal cell carcinoma
por: Liu, Yuenan, et al.
Publicado: (2019)

MMP9 and TYROBP affect the survival of circulating tumor cells in clear cell renal cell carcinoma by adapting to tumor immune microenvironment
por: Guo, Lingyu, et al.
Publicado: (2023)

Overexpression of PLIN2 is a prognostic marker and attenuates tumor progression in clear cell renal cell carcinoma
por: Cao, Qi, et al.
Publicado: (2018)

Low Expression Levels of SLC22A12 Indicates a Poor Prognosis and Progresses Clear Cell Renal Cell Carcinoma
por: Xu, Jiaju, et al.
Publicado: (2021)

CENPA promotes clear cell renal cell carcinoma progression and metastasis via Wnt/β-catenin signaling pathway
por: Wang, Qi, et al.
Publicado: (2021)

Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma
por: Hu, Junhui, et al.
Publicado: (2023)

The Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma
por: Monjaras-Avila, Cesar U., et al.
Publicado: (2023)

G6PD upregulates Cyclin E1 and MMP9 to promote clear cell renal cell carcinoma progression
por: Zhang, Qiao, et al.
Publicado: (2022)

Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer
por: Mehner, Christine, et al.
Publicado: (2014)

TRPM2 facilitates tumor progression of clear cell renal cell carcinoma by relieving Endoplasmic Reticulum Stress
por: Yuan, Hongwei, et al.
Publicado: (2023)

Long noncoding RNA SNHG12 promotes tumour progression and sunitinib resistance by upregulating CDCA3 in renal cell carcinoma
por: Liu, Yuenan, et al.
Publicado: (2020)

Glycogen metabolism is dispensable for tumor progression in clear cell renal cell carcinoma
por: Xie, Hong, et al.
Publicado: (2021)

ENO2 as a Biomarker Regulating Energy Metabolism to Promote Tumor Progression in Clear Cell Renal Cell Carcinoma
por: Shi, Jian, et al.
Publicado: (2023)

MMP9 Processing of HSPB1 Regulates Tumor Progression
por: Choi, Seo-hyun, et al.
Publicado: (2014)

Lactotransferrin Downregulation Drives the Metastatic Progression in Clear Cell Renal Cell Carcinoma
por: Chiu, I-Jen, et al.
Publicado: (2020)

High expression level of MMP9 is associated with poor prognosis in patients with clear cell renal carcinoma
por: Niu, Haitao, et al.
Publicado: (2018)

TMSB10 acts as a biomarker and promotes progression of clear cell renal cell carcinoma
por: Pan, Qiufeng, et al.
Publicado: (2020)

Cyclovirobuxine inhibits the progression of clear cell renal cell carcinoma by suppressing the IGFBP3-AKT/STAT3/MAPK-Snail signalling pathway
por: Liu, Yadong, et al.
Publicado: (2021)

Loss of tumor suppressor IGFBP4 drives epigenetic reprogramming in hepatic carcinogenesis
por: Lee, Ying-Ying, et al.
Publicado: (2018)

Research Progress of Tumor Microenvironment Targeted Therapy for Clear Cell Renal Cell Carcinoma
por: Huang, Yongqiang, et al.
Publicado: (2023)

Analysis of Germline Variants in CDH1, IGFBP3, MMP1, MMP3, STK15 and VEGF in Familial and Sporadic Renal Cell Carcinoma
por: Ricketts, Christopher, et al.
Publicado: (2009)

CGN Correlates With the Prognosis and Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma
por: Tian, Zijian, et al.
Publicado: (2022)

Tumor-associated macrophage-derived chemokine CCL5 facilitates the progression and immunosuppressive tumor microenvironment of clear cell renal cell carcinoma
por: Xu, Wenhao, et al.
Publicado: (2022)

Identification of Immune-Related Cells and Genes in Tumor Microenvironment of Clear Cell Renal Cell Carcinoma
por: Du, Bowen, et al.
Publicado: (2020)

IGLL5 is correlated with tumor‐infiltrating immune cells in clear cell renal cell carcinoma
por: Xia, Zhi‐Nan, et al.
Publicado: (2021)

Prognostic Immunophenotyping Clusters of Clear Cell Renal Cell Carcinoma Defined by the Unique Tumor Immune Microenvironment
por: Xu, Wenhao, et al.
Publicado: (2021)

MMP-9 inhibition promotes anti-tumor immunity through disruption of biochemical and physical barriers to T-cell trafficking to tumors
por: Juric, Vladi, et al.
Publicado: (2018)

Silencing of TGF-β1 in tumor cells impacts MMP-9 in tumor microenvironment
por: Moore-Smith, Lakisha D., et al.
Publicado: (2017)

Prognostic significance and tumor-immune infiltration of mTOR in clear cell renal cell carcinoma
por: Li, Na, et al.
Publicado: (2021)

Comprehensive analysis of pyroptosis regulators and tumor immune microenvironment in clear cell renal cell carcinoma
por: Zhang, Yan, et al.
Publicado: (2021)

FECH Expression Correlates with the Prognosis and Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma
por: Zhong, Guanghui, et al.
Publicado: (2022)

XRCC1 serves as a potential prognostic indicator for clear cell renal cell carcinoma and inhibits its invasion and metastasis through suppressing MMP-2 and MMP-9
por: Liu, Qing-Hua, et al.
Publicado: (2017)

Immunohistochemical Expression of CD44, MMP-2, MMP-9, and Ki-67 as the Prognostic Markers in Non-Clear Cell Renal Cell Carcinomas—A Prospective Cohort Study
por: Chrabańska, Magdalena, et al.
Publicado: (2022)

Immune classification of clear cell renal cell carcinoma
por: Su, Sumeyye, et al.
Publicado: (2021)

Overexpression of FoxM1 is associated with tumor progression in patients with clear cell renal cell carcinoma
por: Xue, Yi-Jun, et al.
Publicado: (2012)

AB055. Overexpression of CENPH is associated with tumor progression and prognosis of clear cell renal cell carcinoma
por: Wu, Song, et al.
Publicado: (2016)

The Arkadia-ESRP2 axis suppresses tumor progression: analyses in clear-cell renal cell carcinoma
por: Mizutani, A, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_tk15ib1ch9pf7ma19pu2mlujj0